The present invention encompasses compounds of general formula (1)
wherein the groups R
1
to R
4
, Q
a
, Q
b
, Q
H
, L and n are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.